# Enveda

> Biotechnology Company in Boulder (CO)

**Wikidata**: [Q94505592](https://www.wikidata.org/wiki/Q94505592)  
**Source**: https://4ort.xyz/entity/enveda

## Summary
Enveda is a biotechnology company based in Boulder, Colorado, founded in April 2019. The company operates at the intersection of artificial intelligence and pharmaceutical science, utilizing machine learning and metabolomics to drive drug discovery and natural product research.

## Key Facts
*   **Founding:** Founded by Viswa Colluru in April 2019.
*   **Location:** Headquarters are located in Boulder, Colorado, United States.
*   **Leadership:** Viswa Colluru serves as the CEO, a position he has held since the company's inception in April 2019.
*   **Industry Focus:** Operates within biotechnology, drug discovery, and the pharmaceutical industry, with a specific focus on natural products.
*   **Technical Approach:** The company integrates artificial intelligence, machine learning, and metabolomics (the study of chemical processes involving metabolites) into its research processes.
*   **Aliases:** Also known as Enveda Therapeutics and Enveda Biosciences.
*   **Affiliations:** Affiliated with researchers Charles Tapley Hoyt (American chemist/programmer) and Daniel Domingo-Fernández (Spanish researcher/bioinformatician).

## FAQs
### Q: When was Enveda founded?
A: Enveda was founded in April 2019 by Viswa Colluru.

### Q: What technologies does Enveda use for drug discovery?
A: Enveda utilizes a combination of artificial intelligence, machine learning, and metabolomics to analyze chemical processes and identify potential therapeutic compounds.

### Q: Where is Enveda headquartered?
A: The company is headquartered in Boulder, Colorado, United States.

## Why It Matters
Enveda represents a modern evolution in the pharmaceutical and biotechnology sectors by bridging the gap between computational data science and biological chemistry. Traditional drug discovery can be time-consuming and resource-intensive; Enveda addresses this by applying advanced machine learning algorithms and artificial intelligence to interpret complex biological data.

Specifically, their focus on metabolomics—the scientific study of chemical processes involving metabolites—allows for a deeper understanding of cellular physiology and disease mechanisms. By integrating these technologies with the study of natural products, Enveda aims to identify novel drug candidates that might be overlooked by conventional methods. This approach positions the company as a significant player in the shift toward data-driven, precision medicine and automated biological research.

## Notable For
*   **AI-Driven Biotech:** Distinguished by its specific application of artificial intelligence and machine learning to the field of metabolomics.
*   **Multi-disciplinary Approach:** Combines expertise in programming, biology, and chemistry, as evidenced by its affiliation with professionals like Charles Tapley Hoyt and Daniel Domingo-Fernández.
*   **Natural Product Focus:** Focuses on natural products within the pharmaceutical industry, leveraging modern tech to explore traditional biological sources.
*   **Strategic Leadership:** Led by founder Viswa Colluru, who has steered the company since its specific inception date in April 2019.

## Body
### Organizational Structure and Identity
Enveda is a private business entity recognized as a biotechnology company. It is interchangeably referred to as Enveda Therapeutics and Enveda Biosciences. The company has been active since its inception on April 1, 2019. It is officially registered with several organizational identifiers, including a ROR ID (04p6vt455), a GRID ID (grid.508354.f), and a Ringgold ID (584973).

### Leadership and Key Personnel
The company was founded by Viswa Colluru, who assumed the role of Chief Executive Officer (CEO) in April 2019. The organization is affiliated with notable scientific researchers:
*   **Charles Tapley Hoyt:** An American chemist, biologist, and programmer.
*   **Daniel Domingo-Fernández:** A Spanish researcher and bioinformatician.

### Scientific Methodology and Industry
Enveda operates across several intersecting industries:
*   **Biotechnology & Pharmaceuticals:** The core sector for the company's business operations.
*   **Artificial Intelligence & Machine Learning:** The company employs computer systems capable of performing tasks without explicit instructions and exhibiting intelligent behavior to process data.
*   **Metabolomics:** A key area of study for the company, focusing on the scientific study of chemical processes involving metabolites.

### Digital Presence
The company maintains an online presence at `https://www.enveda.com` and maintains a LinkedIn profile identified as `envedabio`. It is also tracked on Crunchbase under the organization ID `enveda-therapeutics`.

## Schema Markup
```json
{
  "@context": "https://schema.org",
  "@type": "Organization",
  "name": "Enveda",
  "alternateName": ["Enveda Therapeutics", "Enveda Biosciences"],
  "description": "Biotechnology Company in Boulder (CO)",
  "url": "https://www.enveda.com",
  "foundingDate": "2019-04",
  "founder": {
    "@type": "Person",
    "name": "Viswa Colluru"
  },
  "address": {
    "@type": "PostalAddress",
    "addressLocality": "Boulder",
    "addressCountry": "United States"
  },
  "sameAs": [
    "https://www.linkedin.com/company/envedabio",
    "https://www.crunchbase.com/organization/enveda-therapeutics"
  ]
}